News | RIVM

COVID-19 vaccination starts on BES and CAS islands

44,050 vaccines were delivered to the Caribbean part of the Kingdom of the Netherlands last week. The delivery consisted of vaccines from Moderna and from Pfizer/BioNTech.

RIVM collaborates at European level on the implemention of the Nutri-Score label

The Netherlands, Belgium, France, Germany, Luxembourg, Spain and Switzerland are collaborating to facilitate the nutritional label NutriScore.

First vaccines for people aged 60-64 available Monday via GP

From 15 February on, the first people will be vaccinated against COVID-19 via their GP in the Netherlands. Due to the limited availability of the AstraZeneca vaccine, the first invitations will go to all people born in 1956 or 1957.

First care workers vaccinated with AstraZeneca on Friday

The first AstraZeneca vaccines will be administered in the Netherlands this Friday. This will happen at the GGD vaccination site in The Hague.

People living in small-scale residential facilities vaccinated sooner by deploying Moderna as well as Pfizer/BioNTech

Starting next week, vaccination for clients receiving care under the Long-Term Care Act, who are living in small-scale residential facilities without an institutional physician, will be expanded to the Pfizer/BioNTech vaccine and Moderna vaccine.

Man receives COVID-19 vaccination at GGD vaccination site

Lareb notes newly reported deaths shortly after vaccination

The Pharmacovigilance Centre Lareb announced today that the centre had received a total of 15 reports so far regarding deaths shortly after receiving the COVID-19 vaccinations.

New research in GGD test lanes on spread of coronavirus SARS-CoV-2

RIVM is launching a survey-based study this week on risk factors for the coronavirus SARS-CoV-2. The participants in this study are people who get tested for COVID-19 in a GGD test lane.

80 to 84-year-olds invited for vaccination sooner

Starting tomorrow, the first people in the age group from 80-84 years in the Netherlands will receive an invitation from RIVM for a COVID-19 vaccination.

One person died shortly after COVID-19 vaccination

The Pharmacovigilance Centre Lareb announced today that the centre had received a report of death shortly after receiving the Pfizer/BioNTech COVID-19 vaccination in the Netherlands.

Nationwide assessment of SARS-CoV-2 laboratories: very high quality

The vast majority of the laboratories analysing COVID-19 tests are performing at the very highest standard of quality.